Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2561-2018Class II

1) TVS LPA, Sterile EO, Rx Only, Catalog #: a) KIT-071-01; b) KIT-071-03; c) KIT-071-10; d) KIT-071-11; 2)...

Galt Medical Corp / initiated 2018-05-02 / Terminated / root cause: sterility

Galt Medical Corporation began a recall of 1) TVS LPA, Sterile EO, Rx Only, Catalog #: a) KIT-071-01; b) KIT-071-03; c) KIT-071-10; d) KIT-071-11; 2) Enhance Transcarotid/Peripheral Access Kit, Sterile... on . FDA classified it as Class II and gives the reason as "The products listed might contain unsafe levels of bacterial endotoxins (Pyrogens) that were introduced during a manufacturing step. Bacterial Endotoxins also called pyrogenic bacteria can activate the inflammatory...". As of , the recall status on record is Terminated, and MDM tags the root cause as sterility.

Recall record

Recall number
Z-2561-2018
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Galt Medical Corp
Product
1) TVS LPA, Sterile EO, Rx Only, Catalog #: a) KIT-071-01; b) KIT-071-03; c) KIT-071-10; d) KIT-071-11; 2) Enhance Transcarotid/Peripheral Access Kit, Sterile EO, Rx Only, Catalog #: a) KIT-075-02; b) KIT-075-03
Product code
DRE Dilator, Vessel, For Percutaneous Catheterization
Reason for recall
The products listed might contain unsafe levels of bacterial endotoxins (Pyrogens) that were introduced during a manufacturing step. Bacterial Endotoxins also called pyrogenic bacteria can activate the inflammatory process and produce fever, chills, and hypotension in a patient.
Root cause tag
sterility
FDA root cause
Other
Action
On approximately 05/01/2018 recall letters and customer response forms were mailed to all consignees.
Quantity in commerce
8350
Distribution
U.S.: MN, PA, VA, CA, UT, FL, NY, GA, LA, MO, TX, MS, OH, WA, MA, IL, KY, NC, and Puerto Rico; OUS: Canada, Australia, France, Germany, Ireland, Italy, Netherlands, Poland, Slovakia, Switzerland, Belgium, United Kingdom, Korea
Product codes and lots
Lot #: 1) a) G18046082, G18046083, G18046084, G18046085; b) G18031106, G18031199, G18046076; c) G18030048, G18030049; d) G18030050, G18030204;  2) a) G18003035, G18101170; b) G18003036, G18003037, G18003038

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2561-2018
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2558-2018Class IITerminatedVoluntary: Firm initiated
Z-2559-2018Class IITerminatedVoluntary: Firm initiated
Z-2560-2018Class IITerminatedVoluntary: Firm initiated
Z-2561-2018Class IITerminatedVoluntary: Firm initiated
Z-2562-2018Class IITerminatedVoluntary: Firm initiated
Z-2563-2018Class IITerminatedVoluntary: Firm initiated
Z-2564-2018Class IITerminatedVoluntary: Firm initiated
Z-2565-2018Class IITerminatedVoluntary: Firm initiated